| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.23 | 4e-06 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0005 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.0007 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.18 | 0.0008 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0009 |